Integrated Pharma Services News Today

Initiatives in Maryland for education, environment, and global reach are driving growth across this Mid-Atlantic state.

Grants to Maryland companies manufacturing medical supplies early in the COVID-19 pandemic were successful in the short-term, Department of Commerce data shows, but have made little impact on the state’s manufacturing capability since then. The state invested over $3.1 million in grants of as much as $100,000 to companies that pivoted to manufacture items ...

Tests show Micrillon yarns deactivate human coronavirus Results show significant potential for various applications, including the use of Micrillon yarns in PPE. 20th January 2021 UMF Corporation today announced that testing from award-winning contract research organization Integrated Pharma Services, confirms that it’s Micrillon sheath and core fibre demonstrates significant antiviral properties against Human Coronavirus, which causes COVID-19, and Human Influenza A H1N1 virus in just minute...

Share this article Share this article SKOKIE, Ill., Jan. 19, 2021 /PRNewswire/ -- UMF Corporation today announced that testing from award-winning contract research organization Integrated Pharma Services confirms that UMFs Micrillon® sheath and core fiber demonstrates significant antiviral properties against Human Coronavirus, which causes COVID-19, and Human Influenza A H1N1 virus in just minutes. The Micrillon sheath and core fiber, spun into a yarn and knitted into a material, also demo...